InvestorsObserver is giving Eton Pharmaceuticals Inc (ETON) an Analyst Rating Rank of 75, meaning ETON is ranked higher by analysts than 75% of stocks. The average price target for ETON is $12 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating ETON a Strong Buy today. Find out what this means to you and get the rest of the rankings on ETON!